PAPER Ghebranious N, Mukesh B, Giampietro PF, Glurich I, Mickel SF, Waring SC, McCarty CA
SEARCH RESULTS
330988 RESULTS
PAPER Kuzyk A, Kastyak M, Agrawal V, Gallant M, Sivakumar G, Rak M, Del Bigio MR, Westaway D, Julian R, Gough KM
Association among amyloid plaque, lipid, and creatine in hippocampus of TgCRND8 mouse model for Alzheimer disease.
J Biol Chem. 2010 Oct 8;285(41):31202-7. PubMed: 20682779PAPER Lee AW, Champagne N, Wang X, Su XD, Goodyer C, Leblanc AC
Alternatively spliced caspase-6B isoform inhibits the activation of caspase-6A.
J Biol Chem. 2010 Oct 15;285(42):31974-84. PubMed: 20682790PAPER McEvoy LK, Edland SD, Holland D, Hagler DJ, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM,
Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease.
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):269-77. PubMed: 20683184PAPER Koedam EL, van der Flier WM, Barkhof F, Koene T, Scheltens P, Pijnenburg YA
Clinical characteristics of patients with frontotemporal dementia with and without lobar atrophy on MRI.
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):242-7. PubMed: 20683185PAPER Grober E, Sanders AE, Hall C, Lipton RB
Free and cued selective reminding identifies very mild dementia in primary care.
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):284-90. PubMed: 20683186PAPER Tolboom N, Koedam EL, Schott JM, Yaqub M, Blankenstein MA, Barkhof F, Pijnenburg YA, Lammertsma AA, Scheltens P, van Berckel BN
Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings.
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):303-7. PubMed: 20683187PAPER Jellinger KA
Correspondence regarding: thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol 2010;69:449-54.
J Neuropathol Exp Neurol. 2010 Aug;69(8):864; author reply 864-5. PubMed: 20683236PAPER Seo JS, Jung EY, Kim JH, Lyu YS, Han PL, Kang HW
A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
J Ethnopharmacol. 2010 Jun 1; PubMed: 20685330PAPER Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM, Basil A, Shaw LM, Xie SX, Grady MS, Trojanowski JQ
Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.
Ann Neurol. 2010 Oct;68(4):535-40. PubMed: 20687117PAPER Laxton AW, Tang-Wai DF, McAndrews MP, Zumsteg D, Wennberg R, Keren R, Wherrett J, Naglie G, Hamani C, Smith GS, Lozano AM
A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease.
Ann Neurol. 2010 Oct;68(4):521-34. PubMed: 20687206PAPER Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Ann Neurol. 2010 Sep;68(3):319-29. PubMed: 20687209ASCL1
ANTIBODY polyclonal manufacturer Cat# LS-C97682 immunogen = synthetic peptide selected from the C-terminal region of human Mash1 liquid, PBS, azide, protein G purified ASCL1/ASH1/MASH 1 IgG Transcription Factors LifeSpan Biosciences, Inc. Rabbit Human Mouse ASCL1
ASCL1
ANTIBODY polyclonal manufacturer Cat# ab74624 immunogen = synthetic peptide derived from within residues 150 to the C-terminus of human MASH1/Achaete-scute homolog 1, conj. to KLH liquid, PBS, azide, BSA, affinity purified ASCL1/ASH1/MASH 1 expect rat, cow, dog, m
ASCL1
ANTIBODY polyclonal manufacturer Cat# ab71197 immunogen = synthetic peptide corresp. to aa residues surrounding L68 of human Achaete-scute homolog 1 conjugated to KLH liquid, PBS, azide, ammonium sulfate ppt ASCL1/ASH1/MASH 1 IgG Transcription Factors Abcam Rabbit
Current Filters
No filters selected